Stroke in atrial fibrillation: epidemiology and thromboprophylaxis

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

(2011) John A. Cairns et al.   CANADIAN JOURNAL OF CARDIOLOGY

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

(2011) G. Y. H. Lip et al.   EUROPACE

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation

(2011) Ricarda Marinigh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring

(2011) Giuseppe Boriani et al.   STROKE

Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation

(2010) Gregory Y.H. Lip   AMERICAN JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk

(2010) G. Y. H. Lip   EUROPACE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Stroke Risk Stratification in a “Real-World” Elderly Anticoagulated Atrial Fibrillation Population

(2010) DANIELA POLI et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy

(2010) Tsuneaki Sadanaga et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

(2010) T. P. VAN STAA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Identifying Patients at High Risk for Stroke Despite Anticoagulation

(2010) Gregory Y.H. Lip et al.   STROKE

Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes

(2010) Jeremiah Depta et al.   THROMBOSIS AND HAEMOSTASIS

New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs

(2010) Renato D. Lopes et al.   THROMBOSIS AND HAEMOSTASIS

New oral anticoagulant drugs in cardiovascular disease

(2010) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate

(2010) Gregory Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1

(2010) Laurent Gorin et al.   THROMBOSIS AND HAEMOSTASIS

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice

(2010) Gregory Lip   THROMBOSIS AND HAEMOSTASIS

The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?

(2010) John W. Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.  

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

(2008) GIOVANNI L. BOTTO et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY